4.5 Article

The Absorption Profile of Pregabalin in Chronic Pancreatitis

期刊

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
卷 111, 期 6, 页码 385-390

出版社

WILEY-BLACKWELL
DOI: 10.1111/j.1742-7843.2012.00914.x

关键词

-

资金

  1. Pfizer Research and Development
  2. Pfizer Clinical Research Operations

向作者/读者索取更多资源

It was recently shown that pregabalin decreased pain associated with chronic pancreatitis. It is well known that pancreatitis patients suffer from fat malabsorption with accompanying diarrhoea because of loss of exocrine pancreatic enzyme production. This may lead to changes in the mucosal surface in the small intestine and possibly affect the absorption of pregabalin. The pharmacokinetics of pregabalin has never been investigated in patients suffering from chronic pancreatitis. The aim of this study was to develop a population pharmacokinetic model of pregabalin administered to patients with chronic pancreatitis. The pregabalin population pharmacokinetic analysis was conducted on data from fifteen patients with chronic pancreatitis. Each patient received 75 mg of pregabalin (oral capsule). Pregabalin concentrations were measured using a validated liquid chromatographic method. Data analysis was performed using non-linear mixed effects modelling methodology as implemented by NONMEM. A one-compartment model with first-order absorption and elimination adequately described pregabalin pharmacokinetics. Time to maximum observed plasma concentration (Tmax) was 1.53 (95% CI 1.092.05). The maximum plasma concentration (Cmax) was 1.98 mu g/ml (95% CI 1.692.34), and area under the plasma concentrationtime profile (area under the curve) was 18.2 mu g*hr/ml (95% CI 14.726.3). Pregabalin is well absorbed in patients with chronic pancreatitis, and the pharmacokinetic profile of pregabalin is not extensively affected by chronic pancreatitis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Clinical Course of Medically Managed Patients With Large and Small Duct Chronic Pancreatitis

Marco B. Mahdi, Emily Steinkohl, Vikesh K. Singh, Asbjorn M. Drewes, Jens B. Frokjaer, Soren S. Olesen

Summary: In medically managed patients with chronic pancreatitis, those with large duct CP have a higher prevalence of diabetes and exocrine insufficiency compared to small duct CP. There is also an increased risk of new-onset exocrine insufficiency and higher rates of pancreatic atrophy in patients with large duct CP.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Surgical strategies for chronic pancreatitis in a 1,327-patient Scandinavian Baltic pancreatic Club (SBPC) register

Mikael Parhiala, Anne Waage, Povilas Ignatavicus, Jakob L. Poulsen, Engjom Trond, Georg Dimcevski, Ingrid Nordaas, Amer Hadi, Evangelos Kalaitzakis, Asbjorn M. Drewes, Camilla Nojgaard, Johanna Laukkarinen

Summary: This study aimed to determine the surgical treatment strategies for chronic pancreatitis (CP) in the Scandinavian and Baltic countries. The results showed that only 7% of CP patients underwent pancreatic surgery, with 51% of them undergoing surgery for chronic pain. After surgery, 47% of the patients were pain-free and half of the patients reported no pain.

PANCREATOLOGY (2023)

Article Medicine, Research & Experimental

Cannabis-opioid interaction in the treatment of fibromyalgia pain: an open-label, proof of concept study with randomization between treatment groups: cannabis, oxycodone or cannabis/oxycodone combination-the SPIRAL study

Cornelis Jan van Dam, Monique van Velzen, Cornelis Kramers, Arnt Schellekens, Erik Olofsen, Marieke Niesters, Albert Dahan

Summary: This study aims to investigate whether self-titration of oxycodone and cannabis can reduce side effects in chronic pain patients with fibromyalgia.

TRIALS (2023)

Article Substance Abuse

Alcohol Drinking Patterns and Risk of Developing Acute and Chronic Pancreatitis

Ulrik Becker, Amalie Timmermann, Ola Ekholm, Morten Gronbaek, Asbjorn Mohr Drewes, Srdan Novovic, Camilla Nojgaard, Soren Schou Olesen, Janne Schurmann Tolstrup

Summary: This study analyzed the effects of drinking pattern and type of alcohol on the risk of acute and chronic pancreatitis. The results showed that increased alcohol intake was associated with increased development of pancreatitis. Frequent binge drinking and long-term drinking (daily drinking) were associated with the development of pancreatitis. The intake of large amounts of spirits and beer was associated with the development of acute and chronic pancreatitis, while the consumption of wine was not associated with the development of pancreatitis.

ALCOHOL AND ALCOHOLISM (2023)

Article Pharmacology & Pharmacy

Effects of opium tincture on the enteric and central nervous systems: A randomized controlled trial

Tina Okdahl, Esben Bolvig Mark, Rasmus Bach Nedergaard, Cecilie Siggaard Knoph, Mathias Ellgaard Cook, Klaus Krogh, Asbjorn Mohr Drewes

Summary: Opium tincture, traditionally used for chronic diarrhea, has been found to decrease bowel movements and increase stool consistency without causing sedation. This controlled trial demonstrates that opium tincture has anti-propulsive properties in the healthy gut, making it a relevant and safe treatment option for chronic diarrhea.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2023)

Review Medicine, General & Internal

Opioids in the Treatment of Chronic Idiopathic Diarrhea in Humans-A Systematic Review and Treatment Guideline

Christoffer S. Graven-Nielsen, Cecilie S. Knoph, Tina Okdahl, Katrine L. Hoyer, Klaus Krogh, Per M. Hellstroem, Asbjorn M. Drewes

Summary: In patients with chronic idiopathic diarrhea resistant to standard treatment, opioids are often used as rescue therapy. This systematic review investigated the effects of opioid agonists on gut function in chronic diarrhea. The review found that opioid receptor agonists such as loperamide, asimadoline, casokefamide, and codeine reduced stool frequency and increased transit time compared with placebo, while loperamide and diphenoxylate significantly improved stool consistency. However, the evidence from clinical trials is limited and more research is needed to establish standardized endpoints and larger prospective studies.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Multidisciplinary Sciences

A biomarker of opioid-induced respiratory toxicity in experimental studies

Marieke Hellinga, Marijke Hyke Algera, Rutger van der Schrier, Elise Sarton, Monique van Velzen, Albert Dahan, Erik Olofsen, Marieke Niesters

Summary: The respiratory parameter _V(E)55 from the hypercapnic ventilatory response (HCVR) is the most sensitive biomarker of opioid-induced respiratory depression (OIRD). This finding can be used for standardized comparison of opioids in assessing their safety.

ISCIENCE (2023)

Review Anesthesiology

Prediction of pain using electrocardiographic-derived autonomic measures: A systematic review

Anne-Marie Wegeberg, Trine Hyttel Sejersgaard-Jacobsen, Christina Brock, Asbjorn Mohr Drewes

Summary: Pain is a major clinical challenge, and understanding its pathophysiology is critical for optimal management. This systematic review investigates the ability of electrocardiographic-derived measures to predict pain, and finds that increased parasympathetic activity can predict pain reduction in different types of pain.

EUROPEAN JOURNAL OF PAIN (2023)

Article Gastroenterology & Hepatology

Multistate Model of the Natural History of Inflammatory Pancreatic Diseases: A Nationwide Population-based Cohort Study

Mathias Ellgaard Cook, Niels Henrik Bruun, Line Davidsen, Asbjorn Mohr Drewes, Soren Schou Olesen

Summary: Understanding the nature of inflammatory pancreatic diseases is crucial for healthcare planning. This study found an increased risk of chronic pancreatitis and pancreatic cancer in patients with a history of acute pancreatitis, with most transitioning directly from a healthy state.

GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Risk of pancreatic cancer in people with new-onset diabetes: A Danish nationwide population-based cohort study

Morten Hasselstrom Jensen, Simon Lebech Cichosz, Ole Hejlesen, Stine Dam Henriksen, Asbjorn Mohr Drewes, Soren Schou Olesen

Summary: This nationwide population-based retrospective cohort study examined the 3-year cumulative incidence of pancreatic ductal adenocarcinoma (PDAC) in people 50 years and older with new onset diabetes (NOD). The study found that the risk of PDAC among this population was approximately 0.6%. People with pancreatic cancer-related diabetes (PCRD) had distinct demographic and clinical profiles compared to those with type 2 diabetes (T2D), including different trajectories of plasma HbA1c and triglyceride levels.

PANCREATOLOGY (2023)

Article Gastroenterology & Hepatology

Quality of life after endoscopic procedures for chronic pancreatitis: A multicentre study

Mikael Parhiala, Camilla Nojgaard, Andreas Bartholdy, Anne Waage, Povilas Ignatavicius, Trond Engjom, Georg Dimcevski, Ingrid Kvale Nordaas, Evangelos Kalaitzakis, Asbjorn M. Drewes, Amer Hadi, Soren S. Olesen, Jakob L. Poulsen, Johanna Laukkarinen, Scandinavian Baltic Pancreatic Club

Summary: This study aimed to determine the frequency of endoscopic procedures (EP) in chronic pancreatitis (CP) patients and analyze their pain and quality of life (QoL) after the procedures. The study found that 20% of CP patients underwent EP, and these patients had higher QoL scores and improved symptoms. Patients who had pancreatic stenting had similar pain patterns to the reference population.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2023)

Article Clinical Neurology

Spinal Excitability in Patients with Painful Chronic Pancreatitis

Cecilie Siggaard Knoph, Rasmus Bach Nedergaard, Soren Schou Olesen, Louise Kuhlmann, Asbjorn Mohr Drewes

Summary: Abdominal pain is common in patients with chronic pancreatitis and is difficult to manage due to altered pain processing in the central nervous system. We hypothesized that patients with painful chronic pancreatitis have generalized hyperalgesia and increased central neuronal excitability. Our study confirmed somatic hyperalgesia in these patients, highlighting the importance of targeting central mechanisms for management.

JOURNAL OF PAIN RESEARCH (2023)

Meeting Abstract Anesthesiology

Antagonism of Propofol in Zebrafish by Altering the Comparing Morphine and Hydromorphone Effects and Side Effects - a Crossover Study in Human Volunteers

Konrad Meissner, Albert Dahan, Erik Olofsen, Jane Blood, Johannes Wieditz, Evan Kharasch

ANESTHESIA AND ANALGESIA (2023)

Meeting Abstract Anesthesiology

Evaluation of Two Thermal Pain Models for Assessing Morphine and Hydromorphone Comparative Analgesia in Human Volunteers

Konrad Meissner, Erik Olofsen, Albert Dahan, Johannes Wieditz, Evan Kharasch

ANESTHESIA AND ANALGESIA (2023)

暂无数据